Cargando…
Pioglitazone Ameliorates Renal Ischemia-Reperfusion Injury via Inhibition of NF-κB Activation and Inflammation in Rats
Renal ischemia-reperfusion injury (IRI) is considered as a major cause of acute kidney injury. In this study, we investigated the role of the NF-κB signaling pathway and inflammation in the amelioration of renal IRI using pioglitazone. Sprague–Dawley (SD) rats were subjected to bilateral renal arter...
Autores principales: | Zou, Gaode, Zhou, Zhiyu, Xi, Xiaoqing, Huang, Ruizhen, Hu, Honglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326914/ https://www.ncbi.nlm.nih.gov/pubmed/34349671 http://dx.doi.org/10.3389/fphys.2021.707344 |
Ejemplares similares
-
Pioglitazone Protects Against Renal Ischemia-Reperfusion Injury via the AMP-Activated Protein Kinase-Regulated Autophagy Pathway
por: Chen, Wenlin, et al.
Publicado: (2018) -
Tisp40 Induces Tubular Epithelial Cell GSDMD-Mediated Pyroptosis in Renal Ischemia-Reperfusion Injury via NF-κB Signaling
por: Xiao, Chengcheng, et al.
Publicado: (2020) -
Effects of Farnesiferol B on Ischemia-Reperfusion-Induced Renal Damage, Inflammation, and NF-κB Signaling
por: Zhang, Lu, et al.
Publicado: (2019) -
Ginsenoside Rg1 Ameliorates Rat Myocardial Ischemia-Reperfusion Injury by Modulating Energy Metabolism Pathways
por: Li, Lin, et al.
Publicado: (2018) -
Podocyte NF‐κB is dispensable for the pathogenesis of renal ischemia‐reperfusion injury
por: Yamashita, Maho, et al.
Publicado: (2016)